Reacción #87346

ord-af610b9228b74e4385f79fbcf2cfc184

Condiciones de reacción

Temperatura
40°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Extracciónthe water phase was extracted with ethyl acetate (2×10 mL)
  2. 2
    SecadoThe organic phase was dried over sodium sulfate
  3. 3
    Concentraciónconcentrated
  4. 4
    OtroThe residue was purified on silica gel column

Procedimiento

Concentrated hydrochloric acid (0.202 mL, 2.39 mmol) was added to a solution of 4-(1-ethoxy-vinyl)-N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-6-(1-(2,2,2-trifluoroethoxy)ethyl)-pyrimidin-2-amine (0.38 g, 0.80 mmol) in dioxane (30 mL) and water (3 mL). The solution was heated at 40° C. for 0.5 h, cooled and neutralised with sodium bicarbonate (1 g). Brine was added (5 mL) and the water phase was extracted with ethyl acetate (2×10 mL). The organic phase was dried over sodium sulfate and concentrated. The residue was purified on silica gel column using a gradient 0-4% methanol in dichloromethane as eluent to give the title compound, 330 mg (92%).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09439904B2uspto-grants-2016_09